Skip to main content

Gambhir, Sanjeev Senior Research Fellow

Associate Director –Bioinks and Biomaterials

  • Associate Director –Bioinks and Biomaterials - Translational Research Initiative for Cellular Engineering and Printing
  • Senior Research Fellow - Intelligent Polymer Research Institute 2008 - 2018

Overview


I have been working on different aspects of chemistry for over 30 years include academic research developing innovative materials and its translation to commercial products including active pharmaceutical intermediate in GLP environment.  I have demonstrated ability to turn ideas and innovations into action and outcomes and lead bioinks synthesis and scale up facility at Translational Research Initiative for Cellular Engineering and Printing (TRICEP), University of Wollongong. Being part of a, multidisciplinary team, I am committed to working collaboratively, with high levels of integrity, accountability and professionalism, and with a continual focus on personal and organisational improvement. I have participated and presented in numerous internal, national and international scientific meetings and conferences and published over 60 peer review publications papers as first or co-author in world recognised scientific journals such as Nature Communication, Journal of the American Chemical Society, Advanced Materials, Chemical Science, Energy & Environmental Science and others. My research is cited more than 2730 times and my H-index is 28 (Google Scholar). Under MTP funded project, I have been collaborating with Inventia Life Science Pty Ltd and Professor Fiona Wood from University of Western Australia and have been successful secured funding from Australian Government’s Medical Research Future Fund for developing a 3D bioprinting system for intraoperative skin regeneration.

I have also driven several other projects to successful completion and achieved desired outcome. I have been supervising and mentoring junior staff and students. The diverse knowledge and experience will allow me to fulfil every requirement crucial for this project efficiently and timely.

Top Publications


Research Overview


  • 3D biomaterial printing has emerged as a potentially revolutionary technology, promising to transform both research and medical therapeutics. 3D bioprinting has the capability to bio-fabricate living tissue and organs using a patient’s own cells in conjunction with different biomaterials. Although there has been recent progress in the field and exponential increase in number of publications in last five years, on-demand fabrication of functional and transplantable tissues and organs is still a distant reality. To advance to this point, there are two major technical challenges that must be overcome. The first is expanding upon the limited variety of biomaterials from reliable primary sources and its processing and formulations (bioinks), which currently do not adequately represent the physical, chemical, and biological complexity and diversity of tissues and organs within the human body. Newly developed bioinks and the resulting 3D printed constructs must meet numerous interdependent requirements, including those that lead to optimal printing, structural, and biological outcomes. The second challenge is developing and implementing comprehensive biomaterial ink and printed structure characterisation combined with in vitro and in vivo tissue- and organ-specific evaluation. Once these challenges are overcome, 3D biomaterial printing is proposed to become an indispensable tool for both investigating complex tissue and organ morphogenesis and for developing functional devices for a variety of diagnostic and regenerative medicine applications.

    At Translational Research Initiative for Cellular Engineering and Printing (TRICEP) facility we are addressing the key challenges in 3D bioprinting and committed to translate the research and for creating commercial opportunities. Identification of opportunities with clinical partners, partner SME’s and other industries to enable production of relevant biomaterials and establishing primary sources of biomaterials that is the key for of high quality formulations of bioinks and customised bioprinting solutions.



Selected Publications


Impact Story


Full Name


  • Sanjeev Gambhir

Mailing Address


  • 56 Montague St, ,

    North Wollongong, University of Wollongong

    NSW

    2500

    Australia

Top Publications


Research Overview


  • 3D biomaterial printing has emerged as a potentially revolutionary technology, promising to transform both research and medical therapeutics. 3D bioprinting has the capability to bio-fabricate living tissue and organs using a patient’s own cells in conjunction with different biomaterials. Although there has been recent progress in the field and exponential increase in number of publications in last five years, on-demand fabrication of functional and transplantable tissues and organs is still a distant reality. To advance to this point, there are two major technical challenges that must be overcome. The first is expanding upon the limited variety of biomaterials from reliable primary sources and its processing and formulations (bioinks), which currently do not adequately represent the physical, chemical, and biological complexity and diversity of tissues and organs within the human body. Newly developed bioinks and the resulting 3D printed constructs must meet numerous interdependent requirements, including those that lead to optimal printing, structural, and biological outcomes. The second challenge is developing and implementing comprehensive biomaterial ink and printed structure characterisation combined with in vitro and in vivo tissue- and organ-specific evaluation. Once these challenges are overcome, 3D biomaterial printing is proposed to become an indispensable tool for both investigating complex tissue and organ morphogenesis and for developing functional devices for a variety of diagnostic and regenerative medicine applications.

    At Translational Research Initiative for Cellular Engineering and Printing (TRICEP) facility we are addressing the key challenges in 3D bioprinting and committed to translate the research and for creating commercial opportunities. Identification of opportunities with clinical partners, partner SME’s and other industries to enable production of relevant biomaterials and establishing primary sources of biomaterials that is the key for of high quality formulations of bioinks and customised bioprinting solutions.



Selected Publications


Impact Story


Full Name


  • Sanjeev Gambhir

Mailing Address


  • 56 Montague St, ,

    North Wollongong, University of Wollongong

    NSW

    2500

    Australia